{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:53:41Z","timestamp":1781175221392,"version":"3.54.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:00:00Z","timestamp":1413331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:00:00Z","timestamp":1413331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12016-014-8453-8","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T01:43:47Z","timestamp":1413251027000},"page":"333-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Vasculitides and the Complement System: a Comprehensive Review"],"prefix":"10.1007","volume":"49","author":[{"given":"Maria Sole","family":"Chimenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Ballanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Triggianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,15]]},"reference":[{"key":"8453_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/art.20928","volume":"53","author":"E Reinhold-Keller","year":"2005","unstructured":"Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93\u201399","journal-title":"Arthritis Rheum"},{"key":"8453_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.berh.2012.12.002","volume":"27","author":"R Waller","year":"2013","unstructured":"Waller R, Ahmed A, Patel I, Luqmani R (2013) Update on the classification of vasculitis. Best Pract Res Clin Rheumatol 27:3\u201317","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8453_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.7326\/0003-4819-89-5-660","volume":"89","author":"AS Fauci","year":"1978","unstructured":"Fauci AS, Haynes BF, Katz P (1978) The spectrum of vasculitis: clinical, pathological, immunologic, and therapeutic considerations. Ann Intern Med 89:660\u2013676","journal-title":"Ann Intern Med"},{"key":"8453_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/art.1780370205","volume":"37","author":"JT Lie","year":"1994","unstructured":"Lie JT (1994) Nomenclature and classification of vasculitis: plus \u00e7a change, plus c\u2019est la m\u00eame chose. Arthritis Rheum 37:181\u2013186","journal-title":"Arthritis Rheum"},{"key":"8453_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10157-013-0869-6","volume":"17","author":"JC Jennette","year":"2013","unstructured":"Jennette JC (2013) Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol 17:603\u2013606","journal-title":"Clin Exp Nephrol"},{"key":"8453_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00467-007-0450-1","volume":"22","author":"PA Brogan","year":"2007","unstructured":"Brogan PA (2007) What\u2019s new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 22:1083\u20131094","journal-title":"Pediatr Nephrol"},{"key":"8453_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.89","author":"GS Hoffman","year":"2014","unstructured":"Hoffman GS, Calabrese LH (2014) Vasculitis: determinants of disease patterns. Nat Rev Rheumatol. doi:10.1038\/nrrheum.89","journal-title":"Nat Rev Rheumatol"},{"key":"8453_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310\u2013317","journal-title":"Ann Rheum Dis"},{"key":"8453_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1568010043483890","volume":"3","author":"M Mizuno","year":"2004","unstructured":"Mizuno M, Morgan BP (2004) The possibilities and pitfalls for anti-complement therapies in inflammatory diseases. Curr Drug Targets Inflamm Allergy 3:87\u201396","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"8453_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","volume":"56","author":"E Ballanti","year":"2013","unstructured":"Ballanti E, Perricone C, Greco E, Ballanti MD, Muzio G, Chimenti MS, Perricone R (2013) Complement and autoimmunity. Immunol Res 56:477\u2013491","journal-title":"Immunol Res"},{"key":"8453_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.128.5.991","volume":"128","author":"WH Lay","year":"1968","unstructured":"Lay WH, Nussenzweig V (1968) Receptors for transducing complex of human B elimination of self-reactive B cells up on complement on leukocytes. J Exp Med 128:991\u20131009","journal-title":"J Exp Med"},{"key":"8453_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0065-2776(08)60908-6","volume":"74","author":"MC Carroll","year":"2000","unstructured":"Carroll MC (2000) The role of complement in B cell activation and tolerance. Adv Immunol 74:61\u201388","journal-title":"Adv Immunol"},{"key":"8453_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01320","volume":"420","author":"C Nathan","year":"2002","unstructured":"Nathan C (2002) Points of control in inflammation. Nature 420:846\u2013852","journal-title":"Nature"},{"key":"8453_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaut.2009.11.014","volume":"34","author":"M Chen","year":"2010","unstructured":"Chen M, Daha MR, Kallenberg CG (2010) The complement system in systemic autoimmune disease. J Autoimmun 34:276\u2013286","journal-title":"J Autoimmun"},{"key":"8453_CR15","first-page":"756","volume":"106","author":"W Grotz","year":"2009","unstructured":"Grotz W, Baba HA, Becker JU, Baumg\u00e4rtel MW (2009) Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge. Dtsch Arztebl Int 106:756\u2013763","journal-title":"Dtsch Arztebl Int"},{"key":"8453_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2500\/aap.2007.28.2972","volume":"28","author":"S Chang","year":"2007","unstructured":"Chang S, Carr W (2007) Urticarial vasculitis. Allergy Asthma Proc 28:97\u2013100","journal-title":"Allergy Asthma Proc"},{"key":"8453_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1385\/CRIAI:23:2:201","volume":"23","author":"J Venzor","year":"2002","unstructured":"Venzor J, Lee WL, Huston DP (2002) Urticarial vasculitis. Clin Rev Allergy Immunol 23:201\u2013216","journal-title":"Clin Rev Allergy Immunol"},{"key":"8453_CR18","first-page":"183","volume":"24","author":"DW Lienesch","year":"2006","unstructured":"Lienesch DW, Sherman KE, Metzger A, Shen GQ (2006) Anti-Clq antibodies in patients with chronic hepatitis C infection. Clin Exp Rheumatol 24:183\u2013185","journal-title":"Clin Exp Rheumatol"},{"key":"8453_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11926-009-0060-y","volume":"11","author":"LJ Jara","year":"2009","unstructured":"Jara LJ, Navarro C, Medina G, Vera-Lastra O, Saavedra MA (2009) Hypocomplementemic urticarial vasculitis syndrome. Curr Rheumatol Rep 11:410\u2013415","journal-title":"Curr Rheumatol Rep"},{"key":"8453_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2249.1991.tb05647.x","volume":"83","author":"E Brouwer","year":"1991","unstructured":"Brouwer E, Tervaert JW, Horst G, van der Huitema MG, Giessen M, Limburg PC, Kallenberg CG (1991) Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener\u2019s granulomatosis and clinically related disorders. Clin Exp Immunol 83:379\u2013386","journal-title":"Clin Exp Immunol"},{"key":"8453_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q","volume":"13","author":"JH Stone","year":"2000","unstructured":"Stone JH, Talor M, Stebbing J et al (2000) Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 13:424\u2013434","journal-title":"Arthritis Care Res"},{"key":"8453_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11926-008-0070-1","volume":"10","author":"MI Danila","year":"2008","unstructured":"Danila MI, Bridges SL Jr (2008) Update on pathogenic mechanisms of systemic necrotizing vasculitis. Curr Rheumatol Rep 10:430\u2013435","journal-title":"Curr Rheumatol Rep"},{"key":"8453_CR23","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","volume":"149","author":"JW van der Tervaert","year":"1989","unstructured":"van der Tervaert JW, Woude FJ, Fauci AS et al (1989) Association between active Wegener\u2019s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461\u20132465","journal-title":"Arch Intern Med"},{"key":"8453_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.4049\/jimmunol.0900173","volume":"183","author":"L Franchi","year":"2009","unstructured":"Franchi L, Eigenbrod T, Nunez G (2009) Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183:792\u2013796","journal-title":"J Immunol"},{"key":"8453_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature04515","volume":"440","author":"S Mariathasan","year":"2006","unstructured":"Mariathasan S, Weiss DS, Newton K et al (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228\u2013232","journal-title":"Nature"},{"issue":"2 Suppl","key":"8453_CR26","doi-asserted-by":"publisher","first-page":"S602","DOI":"10.1067\/mai.2003.80","volume":"111","author":"CA Langford","year":"2003","unstructured":"Langford CA (2003) Vasculitis. J Allergy Clin Immunol 111(2 Suppl):S602\u2013S612","journal-title":"J Allergy Clin Immunol"},{"key":"8453_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2796.2006.01698.x","volume":"260","author":"P Lamprecht","year":"2006","unstructured":"Lamprecht P, Csernok E, Gross WL (2006) Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener\u2019s granulomatosis. J Intern Med 260:187\u2013191","journal-title":"J Intern Med"},{"key":"8453_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar2923","volume":"12","author":"B Wilde","year":"2010","unstructured":"Wilde B, Thewissen M, van Damoiseaux J, Paassen P, Witzke O, Tervaert JW (2010) T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis ResTher 12:204","journal-title":"Arthritis ResTher"},{"key":"8453_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11926-010-0138-6","volume":"12","author":"CG Kallenberg","year":"2010","unstructured":"Kallenberg CG (2010) Pathophysiology of ANCA-associated small vessel vasculitis. Curr Rheumatol Rep 12:399\u2013405","journal-title":"Curr Rheumatol Rep"},{"key":"8453_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1681\/ASN.2008050497","volume":"20","author":"A Schreiber","year":"2009","unstructured":"Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R (2009) C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 20:289\u2013298","journal-title":"J Am Soc Nephrol"},{"key":"8453_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","volume":"170","author":"H Xiao","year":"2007","unstructured":"Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC (2007) Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170:52\u201364","journal-title":"Am J Pathol"},{"key":"8453_CR32","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K De Groot","year":"2005","unstructured":"De Groot K, Rasmussen N, Bacon PA et al (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52:2461\u20132469","journal-title":"Arthritis Rheum"},{"key":"8453_CR33","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","volume":"359","author":"C Pagnoux","year":"2008","unstructured":"Pagnoux C, Mahr A, Hamidou MA et al (2008) Azathioprine of methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 359:2790\u20132803","journal-title":"N Engl J Med"},{"key":"8453_CR34","first-page":"583","volume":"14","author":"ED Ballanti","year":"2012","unstructured":"Ballanti ED, Muzio G, Novelli L, Perricone C, Perricone R (2012) Churg-Strauss syndrome with neurologic manifestations: successful treatment with intravenous immunoglobulins. Isr Med Assoc J 14:583\u2013585","journal-title":"Isr Med Assoc J"},{"key":"8453_CR35","first-page":"568","volume":"14","author":"N Svetlicky","year":"2012","unstructured":"Svetlicky N, Blank M, Zandman-Goddard G (2012) The beneficial effects of intravenous immunoglobulin for antineutrophil cytoplasmic antibody-positive vasculitis. Isr Med Assoc J 14:568\u2013569","journal-title":"Isr Med Assoc J"},{"key":"8453_CR36","first-page":"193","volume":"15","author":"A Polachek","year":"2013","unstructured":"Polachek A, Caspi D, Elkayam O (2013) Granulomatosis and polyangiitis: the rituximab option. Isr Med Assoc J 15:193\u2013194","journal-title":"Isr Med Assoc J"},{"key":"8453_CR37","unstructured":"Casian, A. (2011), Plasma exchange for severe renal vasculitis: long-term follow-up of the MEPEX trial. Clin. Exp. Immunol. 164 (Suppl. 1):52"},{"key":"8453_CR38","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1681\/ASN.V10112446","volume":"10","author":"DC Kluth","year":"1999","unstructured":"Kluth DC, Rees AJ (1999) Anti-glomerular basement membrane disease. J Am Soc Nephrol 10:2446\u20132453","journal-title":"J Am Soc Nephrol"},{"key":"8453_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000072022","volume":"94","author":"M Segelmark","year":"2003","unstructured":"Segelmark M, Hellmark T, Wieslander J (2003) The prognostic significance in Goodpasture\u2019s disease of specificity, titre and affinity of anti-glomerular- basement-membrane antibodies. Nephron Clin Pract 94:59\u201368","journal-title":"Nephron Clin Pract"},{"key":"8453_CR40","first-page":"1389","volume":"10","author":"RA Lerner","year":"1999","unstructured":"Lerner RA, Glassock RJ, Dixon FJ (1999) The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Am Soc Nephrol 10:1389\u20131404","journal-title":"J Am Soc Nephrol"},{"key":"8453_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.ajkd.2013.08.032","volume":"63","author":"S Ohlsson","year":"2014","unstructured":"Ohlsson S, Herlitz H, Lundberg S, Selga D, M\u00f6lne J, Wieslander J, Segelmark M (2014) Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease. Am J Kidney Dis 63:289\u2013293","journal-title":"Am J Kidney Dis"},{"key":"8453_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1309\/NPTP-4UKV-7JU3-ELMQ","volume":"125","author":"EG Fischer","year":"2006","unstructured":"Fischer EG, Lager DJ (2006) Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol 125:445\u2013450","journal-title":"Am J Clin Pathol"},{"key":"8453_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2249.1997.4261438.x","volume":"110","author":"NS Sheerin","year":"1997","unstructured":"Sheerin NS, Springall T, Carroll MC, Hartley B, Sacks SH (1997) Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin Exp Immunol 110:403\u2013409","journal-title":"Clin Exp Immunol"},{"key":"8453_CR44","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.4049\/jimmunol.0901301","volume":"183","author":"MA Otten","year":"2009","unstructured":"Otten MA, Groeneveld TW, Flierman R et al (2009) Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice. J Immunol 183:3980\u20133988","journal-title":"J Immunol"},{"key":"8453_CR45","first-page":"14","volume":"21","author":"SY Hu","year":"2013","unstructured":"Hu SY, Jia XY, Yang XW, Yu F, Cui Z, Zhao MH (2013) Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease. BMC Immunol 21:14\u201342","journal-title":"BMC Immunol"},{"key":"8453_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1440-1827.2007.02107.x","volume":"57","author":"S Hisano","year":"2007","unstructured":"Hisano S, Matsushita M, Fujita T, Takeshita M, Iwasaki H (2007) Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis. Pathol Int 57:351\u2013357","journal-title":"Pathol Int"},{"key":"8453_CR47","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2005090923","volume":"17","author":"A Roos","year":"2006","unstructured":"Roos A, Rastaldi MP, Calvaresi N et al (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17:1724\u20131734","journal-title":"J Am Soc Nephrol"},{"key":"8453_CR48","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/j.1582-4934.2008.00350.x","volume":"12","author":"M Harboe","year":"2008","unstructured":"Harboe M, Mollnes TE (2008) The alternative complement pathway revisited. J Cell Mol Med 12:1074\u20131084","journal-title":"J Cell Mol Med"},{"key":"8453_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10875-012-9772-2","volume":"33","author":"R Ma","year":"2013","unstructured":"Ma R, Cui Z, Liao YH, Zhao MH (2013) Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. J Clin Immunol 33:172\u2013178","journal-title":"J Clin Immunol"},{"key":"8453_CR50","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.semarthrit.2012.10.007","volume":"42","author":"UA Syeda","year":"2013","unstructured":"Syeda UA, Singer NG, Magrey M (2013) Anti-glomerular basement membrane antibody disease treated with rituximab: a case based review. Semin Arthritis Rheum 42:567\u2013572","journal-title":"Semin Arthritis Rheum"},{"key":"8453_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/BOR.0b013e328341009f","volume":"23","author":"P Peto","year":"2011","unstructured":"Peto P, Salama AD (2011) Update on anti-glomerular basement membrane disease. Curr Opin Rheumatol 23:32\u201337","journal-title":"Curr Opin Rheumatol"},{"key":"8453_CR52","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.autrev.2013.06.014","volume":"12","author":"F Dammacco","year":"2013","unstructured":"Dammacco F, Battaglia S, Gesualdo L, Racanelli V (2013) Goodpasture\u2019s disease: a report of ten cases and a review of the literature. Autoimmun Rev 12:1101\u20131108","journal-title":"Autoimmun Rev"},{"key":"8453_CR53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clouvel JP, Danon F, Klein M, Seligmann M (1974) Biologic and clinical significance of cryoglobulins. Am J Med 57:775\u2013788","journal-title":"Am J Med"},{"key":"8453_CR54","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.4049\/jimmunol.0902038","volume":"183","author":"D Sansonno","year":"2009","unstructured":"Sansonno D, Tucci FA, Ghebrehiwet B et al (2009) Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage. J Immunol 183:6013\u20136020","journal-title":"J Immunol"},{"key":"8453_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12016-007-8070-x","volume":"35","author":"P Cacoub","year":"2008","unstructured":"Cacoub P, Saadoun D (2008) Hepatitis C virus infection induced vasculitis. Clin Rev Allergy Immunol 35:30\u201339","journal-title":"Clin Rev Allergy Immunol"},{"key":"8453_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/jcp.55.1.4","volume":"55","author":"C Ferri","year":"2002","unstructured":"Ferri C, Zignego AL, Pileri SA (2002) Cryoglobulins J Clin Pathol 55:4\u201313","journal-title":"Cryoglobulins J Clin Pathol"},{"key":"8453_CR57","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/rheumatology\/33.8.791","volume":"33","author":"C Vitali","year":"1994","unstructured":"Vitali C, Ferri C, Nasti P, La Civita L, Mazzantini M, Longombardo G, Bombardieri S (1994) Hypercomplementaemia as a marker of the evolution from benign to malignant B-cell proliferation in patients with type II mixed cryoglobulinaemia. Br J Rheumatol 33:791\u2013792","journal-title":"Br J Rheumatol"},{"key":"8453_CR58","first-page":"77","volume":"32","author":"A Tarantino","year":"1978","unstructured":"Tarantino A, Anelli A, Costantino AD, Vecchi A, Monti G, Massaro L (1978) Serum complement pattern in essential mixed cryoglobulinaemia. Clin Exp Immunol 32:77\u201385","journal-title":"Clin Exp Immunol"},{"key":"8453_CR59","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","volume":"101","author":"DD Sansonno","year":"2003","unstructured":"Sansonno DD, Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101:3818\u20133826","journal-title":"Blood"},{"key":"8453_CR60","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","volume":"116","author":"DR Saadoun","year":"2010","unstructured":"Saadoun DR, Rigon M, Sene D et al (2010) Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia sequential therapy with antiviral agents. Blood 116:326\u2013334","journal-title":"Blood"},{"key":"8453_CR61","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM et al (2010) EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798\u2013806","journal-title":"Ann Rheum Dis"},{"key":"8453_CR62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2215\/CJN.06710810","volume":"6","author":"JC Davin","year":"2011","unstructured":"Davin JC (2011) Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679\u2013689","journal-title":"Clin J Am Soc Nephrol"},{"key":"8453_CR63","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","volume":"110","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 110:2747\u20132771","journal-title":"Circulation"},{"key":"8453_CR64","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","volume":"364","author":"JC Burns","year":"2004","unstructured":"Burns JC, Glod\u00e9 MP (2004) Kawasaki syndrome. Lancet 364:533\u2013544","journal-title":"Lancet"},{"key":"8453_CR65","first-page":"69","volume":"45","author":"AB Hartopo","year":"2013","unstructured":"Hartopo AB, Setianto BY (2013) Coronary artery sequel of Kawasaki disease in adulthood, a concern for internists and cardiologists. Acta Med Indones 45:69\u201375","journal-title":"Acta Med Indones"},{"key":"8453_CR66","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/rheumatology\/kep026","volume":"48","author":"CC Belizna","year":"2008","unstructured":"Belizna CC, Hamidou MA, Levesque H, Guillevin L, Shoenfeld Y (2008) Infection and vasculitis. Rheumatology (Oxford) 48:475\u2013482","journal-title":"Rheumatology (Oxford)"},{"key":"8453_CR67","first-page":"376","volume":"32","author":"Y Kaneda","year":"1983","unstructured":"Kaneda Y (1983) Complement system in immunological disease of infants and children: the role of the complement system in Kawasaki disease. Japanese Journal of Allergology 32:376\u2013385","journal-title":"Japanese Journal of Allergology"},{"key":"8453_CR68","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/0091-6749(94)90362-X","volume":"93","author":"T Kohsaka","year":"1994","unstructured":"Kohsaka T, Abe J, Asahina T, Kobayashi N (1994) Classical pathway complement activation in Kawasaki syndrome. J Allergy Clin Immunol 93:520\u2013525","journal-title":"J Allergy Clin Immunol"},{"key":"8453_CR69","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.21529","volume":"54","author":"MH Biezeveld","year":"2006","unstructured":"Biezeveld MH, Geissler J, Weverling GJ, Kuipers IM, Lam J, Ottenkamp J, Kuijpers TW (2006) Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Arthritis Rheum 54:369\u2013376","journal-title":"Arthritis Rheum"},{"key":"8453_CR70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clim.2014.03.019","volume":"153","author":"A Nakamura","year":"2014","unstructured":"Nakamura A, Okigaki M, Miura N, Suzuki C, Ohno N, Kametani F, Hamaoka K (2014) Involvement of mannose-binding lectin in the pathogenesis of Kawasaki disease-like murine vasculitis. Clin Immunol 153:64\u201372","journal-title":"Clin Immunol"},{"key":"8453_CR71","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1161\/ATVBAHA.111.227652","volume":"31","author":"I Hinterseher","year":"2011","unstructured":"Hinterseher I, Erdman R, Donoso LA et al (2011) Role of complement cascade in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 31:1653\u20131660","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"8453_CR72","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/HCO.0b013e3283588f06","volume":"27","author":"LB Daniels","year":"2012","unstructured":"Daniels LB, Gordon JB, Burns JC (2012) Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol 27:572\u2013577","journal-title":"Curr Opin Cardiol"},{"key":"8453_CR73","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T et al (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE-study): a randomized, open-label, blinded-endpoints trial. Lancet 379:1613\u20131620","journal-title":"Lancet"},{"key":"8453_CR74","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1358\/dot.2010.46.11.1534012","volume":"46","author":"M Cicardi","year":"2010","unstructured":"Cicardi M, Zanichelli A (2010) Replacement therapy with C1 esterase inhibitors for hereditary angioedema. Drugs Today 46:867\u2013874","journal-title":"Drugs Today"},{"key":"8453_CR75","doi-asserted-by":"publisher","first-page":"e72059","DOI":"10.1371\/journal.pone.0072059","volume":"8","author":"C Duehrkop","year":"2013","unstructured":"Duehrkop C, Banz Y, Spirig R et al (2013) C1 esterase inhibitor reduces lower extremity ischemia\/reperfusion injury and associated lung damage. Plos ONE 8:e72059","journal-title":"Plos ONE"},{"key":"8453_CR76","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1681\/ASN.2013010045","volume":"24","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Nester CM, Holanda DG et al (2013) Soluble CR1 therapy improves complement regulation in C3 glomerulopathy. J Am Soc Nephrol 24:1820\u20131829","journal-title":"J Am Soc Nephrol"},{"key":"8453_CR77","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.imbio.2012.07.014","volume":"217","author":"AM Risitano","year":"2012","unstructured":"Risitano AM (2012) Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders. Immunobiology 217:1080\u20131087","journal-title":"Immunobiology"},{"key":"8453_CR78","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-0034-1376521","volume":"40","author":"M Riedl","year":"2014","unstructured":"Riedl M, Orth-H\u00f6ller D, W\u00fcrzner R (2014) An update on the thrombotic microangiopathies hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Semin Thromb Hemost 40:413\u2013415","journal-title":"Semin Thromb Hemost"},{"key":"8453_CR79","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1055\/s-0034-1375299","volume":"40","author":"M Vivarelli","year":"2014","unstructured":"Vivarelli M, Emma F (2014) Treatment of c3 glomerulopathy with complement blockers. Semin Thromb Hemost 40:472\u2013477","journal-title":"Semin Thromb Hemost"},{"key":"8453_CR80","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJMc1106619","volume":"366","author":"S Radhakrishnan","year":"2012","unstructured":"Radhakrishnan S, Lunn A, Kirschfink M et al (2012) Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 366:1165\u20131166","journal-title":"N Engl J Med"},{"key":"8453_CR81","doi-asserted-by":"crossref","unstructured":"Rosenblad, T. Rebetz, J. Johansson, M. B\u00e9k\u00e1ssy, Z. Sartz, L. Karpman, D. (2014), Eculizumab treatment for rescue of renal function in IgA nephropathy. Pediatr. Nephrol. Jun 13","DOI":"10.1007\/s00467-014-2863-y"},{"key":"8453_CR82","unstructured":"Dairaghi, D. Leleti, M. Miao, S. et al. Clinical dose selection of the C5a receptor antagonist CCX168 for the phase 2 ANCA-associated renal vasculitis clinical trial (the CLEAR trial), 49th European Renal Association\u2013European Dialysis and Transplant Association (ERA\u2013EDTA) Congress, 2012, (Paris, France)."},{"issue":"Suppl 1","key":"8453_CR83","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-2249.2009.04024.x","volume":"158","author":"HP Hartung","year":"2009","unstructured":"Hartung HP, Mouthon L, Ahmed R, Jordan S, Laupland KB, Jolles S (2009) Clinical applications of intravenous immunoglobulins (IVIg)\u2014beyond immunodeficiencies and neurology. Clin Exp Immunol 158(Suppl 1):23\u201333","journal-title":"Clin Exp Immunol"},{"key":"8453_CR84","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","volume":"127","author":"M Ballow","year":"2011","unstructured":"Ballow M (2011) The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 127:315\u2013323","journal-title":"J Allergy Clin Immunol"},{"key":"8453_CR85","doi-asserted-by":"crossref","unstructured":"Smith, R.M. Jones, R.B. Jayne, D.R. (2012), Progress in treatment of ANCA-associated vasculitis. Arthritis Res. Ther.14, 210.","DOI":"10.1186\/ar3797"},{"key":"8453_CR86","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"DR Jayne","year":"2000","unstructured":"Jayne DR, Chapel H, Adu D, Misbah S, O\u2019Donoghue D, Scott D, Lockwood CM (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433\u2013439","journal-title":"QJM"},{"key":"8453_CR87","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/art.23147","volume":"58","author":"V Martinez","year":"2008","unstructured":"Martinez V, Cohen P, Pagnoux C et al (2008) French Vasculitis Study Group. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum 58:308\u2013317","journal-title":"Arthritis Rheum"},{"key":"8453_CR88","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0161-5890(03)00111-1","volume":"40","author":"BP Morgan","year":"2003","unstructured":"Morgan BP, Harris CL (2003) Complement therapeutics; history and current progress. Mol Immunol 40:159\u2013170","journal-title":"Mol Immunol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8453-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-014-8453-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8453-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8453-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:15:22Z","timestamp":1659093322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-014-8453-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,15]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8453"],"URL":"https:\/\/doi.org\/10.1007\/s12016-014-8453-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,15]]},"assertion":[{"value":"15 October 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}